Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies.
作者信息
Lin Yu-Hsiang, Juang Horng-Heng
机构信息
Department of Urology, Chang Gung Memorial Hospital at Linkou, Taoyuan, Taiwan.
School of Medicine, Chang Gung University, Taoyuan, Taiwan.
出版信息
Eur J Neurol. 2024 May;31(5):e16220. doi: 10.1111/ene.16220. Epub 2024 Jan 18.
Abstract
摘要
相似文献
1
Melatonin's role in managing nocturia in Parkinson disease: A critical examination of recent studies.
Eur J Neurol. 2024 May;31(5):e16220. doi: 10.1111/ene.16220. Epub 2024 Jan 18.
2
Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.
Eur J Neurol. 2021 Jun;28(6):1884-1892. doi: 10.1111/ene.14774. Epub 2021 Mar 14.
3
Melatonin's protective effect against UV radiation: a systematic review of clinical and experimental studies.
Photodermatol Photoimmunol Photomed. 2014 Aug;30(4):180-8. doi: 10.1111/phpp.12080. Epub 2013 Nov 17.
4
Effects of melatonin and rilmazafone on nocturia in the elderly.
J Int Med Res. 2007 Sep-Oct;35(5):685-91. doi: 10.1177/147323000703500513.
5
Therapeutic role of melatonin in migraine prophylaxis: A systematic review.
Medicine (Baltimore). 2019 Jan;98(3):e14099. doi: 10.1097/MD.0000000000014099.
6
Melatonin Treatment of Visual Hallucinations in Parkinson Disease.
J Clin Psychopharmacol. 2018 Oct;38(5):532-534. doi: 10.1097/JCP.0000000000000930.
7
Protocol for a randomized, double blind, placebo controlled, crossover trial of Melatonin for treatment of Nocturia in adults with Multiple Sclerosis (MeNiMS).
BMC Neurol. 2017 Mar 27;17(1):63. doi: 10.1186/s12883-017-0845-y.
8
Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).
BMC Neurol. 2018 Aug 6;18(1):107. doi: 10.1186/s12883-018-1114-4.
9
Melatonin's Antineoplastic Potential Against Glioblastoma.
Cells. 2020 Mar 3;9(3):599. doi: 10.3390/cells9030599.
10
Particular phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN mediates melatonin's neuroprotective activity after focal cerebral ischemia in mice.
Redox Biol. 2017 Aug;12:657-665. doi: 10.1016/j.redox.2017.04.006. Epub 2017 Apr 5.
引用本文的文献
1
Nocturia: An overview of current evaluation and treatment strategies.
World J Methodol. 2025 Dec 20;15(4):104696. doi: 10.5662/wjm.v15.i4.104696.
本文引用的文献
1
Exploratory pilot study of exogenous sustained-release melatonin on nocturia in Parkinson's disease.
Eur J Neurol. 2021 Jun;28(6):1884-1892. doi: 10.1111/ene.14774. Epub 2021 Mar 14.
2
The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
J Physiol Pharmacol. 2014 Dec;65(6):777-84.
3
Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort.
J Urol. 2014 Jun;191(6):1816-21. doi: 10.1016/j.juro.2013.12.043. Epub 2013 Dec 30.
4
Melatonin pharmacotherapy for nocturia in men with benign prostatic enlargement.
J Urol. 2004 Mar;171(3):1199-202. doi: 10.1097/01.ju.0000110442.47593.ea.
5
The effect of melatonin administration on pituitary hormone secretion in man.
Clin Endocrinol (Oxf). 1999 Nov;51(5):637-42. doi: 10.1046/j.1365-2265.1999.00820.x.
Zotero 插件